Hryshko LV - Search Results

1

Therapeutic potential of novel Na+-Ca2+ exchange inhibitors in attenuating ischemia-reperfusion injury.

Lee C, Dhalla NS, Hryshko LV. Lee C, et al. Among authors: hryshko lv. Can J Cardiol. 2005 May 1;21(6):509-16. Can J Cardiol. 2005. PMID: 15917880 Review.

2

Activation of proteolytic enzymes and depression of the sarcolemmal Na+/K+-ATPase in ischemia-reperfused heart may be mediated through oxidative stress.

Singh RB, Hryshko L, Freed D, Dhalla NS. Singh RB, et al. Can J Physiol Pharmacol. 2012 Feb;90(2):249-60. doi: 10.1139/y11-128. Epub 2012 Feb 8. Can J Physiol Pharmacol. 2012. PMID: 22316244

3

Inhibitory profile of SEA0400 [2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] assessed on the cardiac Na+-Ca2+ exchanger, NCX1.1.

Lee C, Visen NS, Dhalla NS, Le HD, Isaac M, Choptiany P, Gross G, Omelchenko A, Matsuda T, Baba A, Takahashi K, Hnatowich M, Hryshko LV. Lee C, et al. Among authors: hryshko lv. J Pharmacol Exp Ther. 2004 Nov;311(2):748-57. doi: 10.1124/jpet.104.070805. Epub 2004 Jul 1. J Pharmacol Exp Ther. 2004. PMID: 15231867

4

SEA0400: a novel sodium-calcium exchange inhibitor with cardioprotective properties.

Lee C, Hryshko LV. Lee C, et al. Among authors: hryshko lv. Cardiovasc Drug Rev. 2004 Winter;22(4):334-47. doi: 10.1111/j.1527-3466.2004.tb00150.x. Cardiovasc Drug Rev. 2004. PMID: 15592578 Review.

5

Extracellular and intracellular proteases in cardiac dysfunction due to ischemia-reperfusion injury.

Müller AL, Hryshko LV, Dhalla NS. Müller AL, et al. Among authors: hryshko lv. Int J Cardiol. 2013 Mar 20;164(1):39-47. doi: 10.1016/j.ijcard.2012.01.103. Epub 2012 Feb 20. Int J Cardiol. 2013. PMID: 22357424 Review.

6

Implications of protease activation in cardiac dysfunction and development of genetic cardiomyopathy in hamsters.

Müller AL, Freed D, Hryshko L, Dhalla NS. Müller AL, et al. Can J Physiol Pharmacol. 2012 Aug;90(8):995-1004. doi: 10.1139/y2012-034. Epub 2012 Jul 11. Can J Physiol Pharmacol. 2012. PMID: 22784245 Review.

7

Modification of Ca(2+)-handling in cardiomyocytes by redox sensitive mechanisms in response to ouabain.

Saini-Chohan HK, Hryshko L, Xu YJ, Dhalla NS. Saini-Chohan HK, et al. Can J Physiol Pharmacol. 2013 Jan;91(1):45-55. doi: 10.1139/cjpp-2012-0215. Epub 2013 Jan 24. Can J Physiol Pharmacol. 2013. PMID: 23367872

8

Inhibition of Na+/Ca2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences.

Elias CL, Lukas A, Shurraw S, Scott J, Omelchenko A, Gross GJ, Hnatowich M, Hryshko LV. Elias CL, et al. Among authors: hryshko lv. Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1334-45. doi: 10.1152/ajpheart.2001.281.3.H1334. Am J Physiol Heart Circ Physiol. 2001. PMID: 11514305 Free article.

9

Adenovirally delivered shRNA strongly inhibits Na+-Ca2+ exchanger expression but does not prevent contraction of neonatal cardiomyocytes.

Hurtado C, Ander BP, Maddaford TG, Lukas A, Hryshko LV, Pierce GN. Hurtado C, et al. Among authors: hryshko lv. J Mol Cell Cardiol. 2005 Apr;38(4):647-54. doi: 10.1016/j.yjmcc.2005.02.007. J Mol Cell Cardiol. 2005. PMID: 15808841

10

Effects of SEA0400 on mutant NCX1.1 Na+-Ca2+ exchangers with altered ionic regulation.

Bouchard R, Omelchenko A, Le HD, Choptiany P, Matsuda T, Baba A, Takahashi K, Nicoll DA, Philipson KD, Hnatowich M, Hryshko LV. Bouchard R, et al. Among authors: hryshko lv. Mol Pharmacol. 2004 Mar;65(3):802-10. doi: 10.1124/mol.65.3.802. Mol Pharmacol. 2004. PMID: 14978259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters